Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
9.62
-0.46 (-4.61%)
Apr 29, 2026, 1:04 PM EDT - Market open
Beta Bionics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 30.21 | 31.58 | 30.43 | 26.57 | 27.68 |
| Short-Term Investments | 169.31 | 187.55 | 73.14 | 70.18 | - |
| Cash & Short-Term Investments | 199.52 | 219.13 | 103.58 | 96.75 | 27.68 |
| Cash Growth | -13.80% | 111.56% | 7.06% | 249.58% | - |
| Accounts Receivable | 15.75 | 17.12 | 12 | 4.45 | - |
| Other Receivables | 2.39 | 2.78 | 1.05 | - | - |
| Receivables | 18.14 | 19.89 | 13.05 | 4.45 | - |
| Inventory | 23.73 | 21.72 | 13.32 | 1.25 | - |
| Prepaid Expenses | 6.5 | 7.06 | 2.98 | 0.91 | 0.54 |
| Restricted Cash | 0.1 | 0.1 | - | - | - |
| Other Current Assets | - | - | - | 0.28 | 0.25 |
| Total Current Assets | 247.99 | 267.91 | 132.92 | 103.62 | 28.47 |
| Property, Plant & Equipment | 16.39 | 15.23 | 11.42 | 6.2 | 6.87 |
| Long-Term Investments | 39.87 | 45.43 | - | - | - |
| Long-Term Deferred Charges | - | - | 5.05 | - | - |
| Other Long-Term Assets | 0.18 | 0.18 | 0.25 | 0.22 | 0.19 |
| Total Assets | 304.42 | 328.74 | 149.65 | 110.04 | 35.53 |
| Accounts Payable | 2.32 | 5 | 2.85 | 1.17 | 0.43 |
| Accrued Expenses | 13.18 | 17.34 | 13.33 | 7.07 | 6.14 |
| Current Portion of Leases | 1.84 | 1.94 | 1.53 | 1.22 | 0.98 |
| Current Unearned Revenue | 1.71 | 1.56 | 0.94 | 0.09 | - |
| Other Current Liabilities | 4.15 | 5.1 | 2.5 | 1.05 | 1.32 |
| Total Current Liabilities | 23.19 | 30.92 | 21.15 | 10.61 | 8.87 |
| Long-Term Leases | 5.07 | 5.37 | 5.73 | 3 | 3.16 |
| Long-Term Unearned Revenue | 3.35 | 3.3 | 1.86 | 0.26 | - |
| Other Long-Term Liabilities | 1.56 | 1.55 | 44.9 | 37.57 | 10.5 |
| Total Liabilities | 33.17 | 41.13 | 73.63 | 51.43 | 22.53 |
| Common Stock | 0.01 | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 663.17 | 657.14 | 51.31 | 26.42 | 15.53 |
| Retained Earnings | -391.83 | -369.94 | -296.74 | -229.66 | -185.57 |
| Comprehensive Income & Other | -0.1 | 0.4 | 0.07 | 0.14 | - |
| Total Common Equity | 271.25 | 287.61 | -245.36 | -203.11 | -170.03 |
| Shareholders' Equity | 271.25 | 287.61 | 76.01 | 58.61 | 13 |
| Total Liabilities & Equity | 304.42 | 328.74 | 149.65 | 110.04 | 35.53 |
| Total Debt | 6.91 | 7.3 | 7.26 | 4.22 | 4.13 |
| Net Cash (Debt) | 192.61 | 211.82 | 96.32 | 92.52 | 23.54 |
| Net Cash Growth | -14.21% | 119.91% | 4.11% | 293.01% | - |
| Net Cash Per Share | 4.38 | 5.23 | 15.13 | 17.44 | 4.71 |
| Filing Date Shares Outstanding | 44.56 | 44.38 | 43.35 | 5.03 | 5 |
| Total Common Shares Outstanding | 44.56 | 44.36 | 6.67 | 5.03 | 5 |
| Working Capital | 224.8 | 236.98 | 111.78 | 93.02 | 19.59 |
| Book Value Per Share | 6.09 | 6.48 | -36.80 | -40.39 | -34.02 |
| Tangible Book Value | 271.25 | 287.61 | -245.36 | -203.11 | -170.03 |
| Tangible Book Value Per Share | 6.09 | 6.48 | -36.80 | -40.39 | -34.02 |
| Machinery | 12.23 | 10.19 | 7.48 | 5.78 | 5.56 |
| Construction In Progress | 3.41 | 3.34 | 1.74 | 0.17 | 0.18 |
| Leasehold Improvements | 0.86 | 0.83 | 0.81 | 0.95 | 0.95 |
Source: S&P Capital IQ. Standard template. Financial Sources.